PharmEasy is one of India's leading digital healthcare platforms that offers online pharmacy services, diagnostic testing, and telehealth consultations. The platform enables customers to order medicines online, book diagnostic tests, and access healthcare services conveniently through mobile and web platforms.
PharmEasy operates under API Holdings and has rapidly grown to become one of the most recognized digital health brands in India. The company has expanded its presence through acquisitions and partnerships with diagnostic laboratories and healthcare providers.
Due to the rapid growth of India's digital healthcare ecosystem and increasing demand for online pharmacy services, PharmEasy unlisted shares have gained attention from investors seeking exposure to the healthcare technology sector.
Fundamentals
Market Cap
₹9,500 Cr
P/E Ratio
NA
P/B Ratio
3.2
ROE
NA
Face Value
₹10
Lot Size
100 Shares
Financials
Year
Revenue
Profit
2022
₹5,700 Cr
-₹2,600 Cr
2023
₹6,200 Cr
-₹1,900 Cr
2024
₹6,900 Cr
-₹1,200 Cr
Shareholding Pattern
Promoters
Institutions
Public
Latest News & Events
Growth in digital healthcare and online pharmacy services 2026
Expansion of diagnostic testing and telemedicine services 2025
Rising demand for digital health platforms in India 2024